Introduction
Topical corticosteroids are used for a broad range of inflammatory skin conditions. Side effects are rare and usually seen after prolonged application over months and years. The most frequent delayed side effects are skin atrophy, hypertrichosis, telangiectasia, steroid-induced acne and flare of perioral dermatitis. Immediate adverse reactions to topical corticosteroids are usually brief and include a burning or itchy sensation. This usually does not lead to a discontinuation of the drug. Coombs type IV, delayed-type hypersensitivity reactions to corticosteroids are well known [1] , whereas immediate-type hypersensitivity reactions are very rare. However, the increasing number of patients with positive skin tests (prick and intradermal tests) for glucocorticoids indicates that immediate-type hypersensitivity to glucocorticoids occurs [2] [3] [4] . However, only in a few cases, a presence of specific immunoglobulin E (IgE) in reaction to glucocorticoids was documented by the Radio-AllergoSorbent-Test method [5, 6] . Anaphylaxis and death have been reported in reaction to the systemic administration of corticosteroids [7] . There are more than 100 published reports of immediate hypersensitiv-ity reactions occurring after oral and parenteral administration of corticosteroids [5, 8] . Other than in delayed-type reactions, no clear cross-reactive patterns between corticosteroid classes could be demonstrated in immediate-type reactions [9] . Only one report of anaphylaxis after the use of a topical corticosteroid cream could be found, and it was probably elicited by neomycin, which was present in the formulation [10] .
Maibach and Johnson [11] defined the contact urticaria syndrome in 1975; since then, numerous reports of the contact urticaria syndrome caused by a variety of compounds have been reported. The contact urticaria syndrome can be described in two broad categories: nonimmunologic contact urticaria (type A) and immunologic contact urticaria (type B). Examples of type A contact urticaria are the skin reaction seen after exposure to jellyfish or nettles where a histamine release occurs without involving an immunologic process. Type B contact urticaria is less common in clinical practice than nonimmunologic contact urticaria. Type B contact urticaria is a Coombs type I hypersensitivity reaction mediated by IgE antibodies specific to the eliciting substance. Therefore, prior sensitization is required for this Contact Urticaria and Hexylene Glycol Dermatology 2010;220:238-242 239 type. Immunologic contact urticaria reactions may typically spread beyond the site of contact and progress to generalized urticaria. If more severe, immunologic contact urticaria may lead to anaphylactic shock. One such example is immunologic contact urticaria from natural rubber latex.
One year later, Odom and Maibach [12] added a type C contact urticaria syndrome for those cases where neither an immunologic nor a nonimmunologic mechanism had been identified [13] . Although a histamine release from mast cells is likely to be involved, it is unknown whether degranulation is initiated immunologically or by direct action on the mast cells in those cases [14] .
We report a case of contact urticaria with systemic involvement resembling an anaphylactic reaction, following the application of a topical corticosteroid. This was caused by hexylene glycol, an excipient in the formulation. The allergenic potential of glycols is reviewed. Written informed consent was obtained from the patient for the publication of this case report and accompanying images.
Case Report
In January 2009, a 30-year-old, nonatopic male patient presented to his general practitioner, complaining of burning and dry skin on his back after a holiday in Brazil. He had neither a history of atopic diseases nor of contact hypersensitivity. He was prescribed topical mometasone furoate cream (class III topical corticosteroid). The same night, he applied the cream on his back for the first time and after a few minutes felt a burning sensation, followed by angioedema (tongue and eyelids) and dyspnea after 45 min. A shower did not relieve the symptoms, and the patient presented to the emergency department where the physician documented an urticarial skin reaction. Angioedema was absent at this point. Two hours later, the patient was dismissed in good condition, eupneic and with a completely abated skin rash after treatment with antihistamines.
One month later, skin prick tests were performed, showing no reaction to common allergens (pollen, house dust mites, pets, molds and latex). An open provocation test with mometasone furoate cream and ointment was performed in both cubital folds. After about 20 min, an urticarial rash appeared on both sides ( fig. 1 ). The common contents of both formulations, the cream and the ointment, are the following: mometasone furoate, hexylene glycol, purified water, phosphoric acid, propylene glycol stearate, white wax and white petrolatum.
Skin prick tests with a topical corticosteroid patch series and Nasonex (mometasone furoate nasal spray) were negative. Skin prick tests with solid and fluid propylene glycol up to a 50% concentration were negative. Intracutaneous tests with Macrogol (polyethylene glycol or PEG) 400 and 6000 were also negative for concentrations up to 10%. Prick tests with white petrolatum, PEG DAB 8 and Physiogel cream (pentylene glycol) were also negative ( table 1 ) Retrospectively, the patient remembered having reacted in the past to a shampoo with a burning sensation on the head; however, he did not remember the brand name. Blood tests could not be performed due to aichmophobia (panic disorder regarding needles). The patient was advised to avoid hexylene-glycol-containing topical agents and shampoos and had no skin reaction ever since.
Discussion
Glycols are alcohols containing two hydroxyl groups (diols) ( fig. 3 ). In medicine, PEG are the most widely used glycols. The numbers that are often included in the names of PEG indicate their average molecular weight, e.g. a PEG with an average molecular weight of approximately 400 Da would be labeled PEG 400. With increasing chain length, the preparation takes on the characteristics of a gel rather than a liquid [15] . The monomer, ethylene glycol, is notoriously toxic, being the solvent used in an 'elixir' that killed over 100 people in 1937 [15] . Toxicity has been reported for propylene glycol and PEG in parenteral administration, especially at high doses and in patients with renal impairment [15] . PEG are the basis of a number of laxatives, skin creams and sexual lubricants, frequently combined with glycerine. They are also used in a number of toothpastes as a dispersant; they bind water and help to retain a uniform distribution of gum in the toothpaste. When attached to various protein medications, e.g. PEG-interferon-␣ , PEG slows the clearance of the therapeutic protein, allowing longer dosing intervals. A conjugation of allergens with PEG often increases tolerogenity [16] [17] [18] . This has been studied in immunotherapy [18, 19] and more recently in drug development [20] . Paradoxically, PEG also have a potential to cause immediate-type hypersensitivity reactions [21] [22] [23] . Anaphylaxis, asthma, angioedema and urticaria have been described after the administration of oral PEG electrolyte lavage solutions [24] [25] [26] [27] . Recently, anaphylaxis has also been reported after tablets and intraarticular corticosteroid injections where PEG was used as a vehicle and an excipient, respectively [23, 28] . Phadia AB (Uppsala, Sweden) has recently developed a modified fig. 3 ). Propylene glycol is used as a humectant food additive (E1520), as a moisturizer in cosmetics, food, toothpaste, mouth wash and tobacco products, as the main ingredient in deodorant sticks, as an antifreeze liquid and as a solvent in many pharmaceuticals including oral, injectable and topical formulations. Notably, in diazepam, which is insoluble in water, propylene glycol is used as a solvent in its injectable form.
Hexylene glycol (2-methyl-pentane-2,4-diol) ( fig. 3 ) is mainly found in industrial coatings (paints, lacquers and varnishes), in leather and textile processing as a moistening and softening agent, in antifreeze fluids, and in cosmetics and topical drugs (especially topical corticosteroids) at concentrations between 0.1 and 25%. Hexylene glycol is not as widely used as pentylene glycol in dermatological products [29] , but is an ingredient in the corticosteroid preparation of Elocom (Schering-Plough).
Propylene glycol and hexylene glycol seem to act as sensitizers in contact allergy [30] [31] [32] [33] , i.e. delayed-type hypersensitivity reactions. In this context, cross-reactivity between propylene glycol and hexylene glycol has been described [34] .
The incidence of propylene glycol contact allergy among patients with eczema has been evaluated to be greater than 2% [35] . Contact dermatitis in reaction to propylene glycol in calcipotriene ointment and an ultrasonic gel [36] [37] [38] [39] , as well as in an antiviral cream (Zovirax ) [40] , has been reported. Flares of contact dermatitis following the ingestion of foods containing propylene glycol have been noticed [30] , and systemic contact dermatitis due to intravenous propylene glycol in diazepam (Valium ) in a patient sensitized to propylene glycol has been reported [41] . One report described contact urticaria in reaction to a corticoid cream containing propylene glycol, the responsible chemical, however, was found to be polysorbate 60, a mixture of stearate ester of sorbitol and sorbitol anhydrides [42] . Contact urticaria could not be observed in experiments with open propylene glycol application [43] ; only one report describes nonimmunologic contact urticaria after topical propylene glycol application [44] .
Less is known about the incidence of hypersensitivity to hexylene glycol. In a first human study, 5 human subjects were given oral doses of 37 g of hexylene glycol daily for 24 days (estimated daily dosage: 14-28 mg/kg body weight). No subjective symptoms that could be attributed to the intake of hexylene glycol were reported [45] . First clues pointing to a sensitizing potential were seen in patch tests where hexylene glycol (10% aqueous) was tested in a group of 230 patients with occupational dermatitis in the metallurgic industry. Nine patients had a positive patch test with hexylene glycol (3.9% of the total number tested) [33] . An unclear reaction was reported in 2.8% of 823 eczema patients tested by patch tests with hexylene glycol at aqueous concentrations of 30 or 50% (48-hour occlusion): they showed edema and erythema of the skin; the authors considered this indicative of an irritation rather than a contact allergy [46] . In a further study, mometasone furoate 0.1% fatty cream (containing hexylene glycol, as in the present case) was applied twice weekly for 6 months. Among the 68 patients with atopic dermatitis, 4 showed adverse events related to the treatment: 2 showed folliculitis, 1 skin atrophy and 1 sensation of increased warmth [47] . It has not been mentioned whether the last was an urticarial skin reaction or not. Otherwise, so far no reports are present in the literature describing an immediate-type reaction to hexylene glycol.
Our patient had a contact urticaria with systemic involvement following the application of a topical corticosteroid cream due to hexylene glycol which was present in the formulation. An open application of diluted pure hexylene glycol elicited contact urticaria, confirming its causative role. The systemic involvement and the possibility of a previous exposure and sensitization in our patient together with the negative tests in the controls favor an immunologically mediated process, but this could not be supported by specific IgE. Because no immunological test could be performed due to severe aichmophobia in our patient, the pathogenetic process could not be further elucidated. Therefore, we consider this to be a type C contact urticaria syndrome. In our tests with other glycols, no cross-reactivity to propylene glycol or PEG could be detected. With strict avoidance of hexylene glycol contact, the patient remained free of symptoms. 
